No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SLNCF SILENCE THERAPEUTICS PLC
- 7.600
- 0.0000.00%
15min DelayClose Jul 22 16:00 ET
1.06BMarket Cap-19095P/E (TTM)
7.600High7.600Low700Volume7.600Open7.600Pre Close5.32KTurnover0.00%Turnover RatioLossP/E (Static)139.98MShares14.75052wk High6.64P/B673.21MFloat Cap0.60052wk Low--Dividend TTM88.58MShs Float46.500Historical High--Div YieldTTM0.00%Amplitude0.600Historical Low7.600Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Silence Therapeutics PLC : Morgan Stanley Raises Target Price to $49.00 From $45.00
Express News | Silence Therapeutics PLC: Divesiran Was Well Tolerated
Express News | Silence Therapeutics: Divesiran Eliminated Need for Phlebotomy in All Well-Controlled Patients Following Infrequent Dosing
Express News | Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study of Divesiran in Polycythemia Vera Patients
Express News | Silence Therapeutics: Study Demonstrated Highly Significant and Sustained Reductions in LP(a) to Week 48
Express News | Silence Therapeutics Announces Positive Topline 48-Week Data From Phase 2 Study of Zerlasiran in Patients With Elevated Lipoprotein(a)
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg